Society of University Surgeons| Volume 154, ISSUE 3, P496-503, September 2013

Irreversible electroporation facilitates gene transfer of a GM-CSF plasmid with a local and systemic response


      Electroporation uses an electric field to induce pores in the cell membrane that can transfer macromolecules into target cells. Modulation of electrical parameters leads to irreversible electroporation (IRE), which is being developed for tissue ablation. We sought to evaluate whether the application of IRE may induce a lesser electric field in the periphery where reversible electroporation may occur, facilitating gene transfer of a granulocyte macrophage colony-stimulating factor (GM-CSF) plasmid to produce its biologic response.


      Yorkshire pigs underwent laparotomy, and IRE of the liver was performed during hepatic arterial infusion of 1 or 7 mg of a naked human GM-CSF plasmid. The serum, liver, lymph nodes, and bone marrow were harvested for analysis.


      Human GM-CSF level rose from undetectable to 131 pg/mL in the serum at 24 hours after IRE and plasmid infusion. The liver demonstrated an ablation zone surrounded by an immune infiltrate that had greater macrophage intensity than when treated with IRE or plasmid infusion alone. This dominance of macrophages was dose dependent. Distant effects of GM-CSF were found in the bone marrow, where proliferating myeloid cells increased from 14% to 25%.


      IRE facilitated gene transfer of the GM-CSF plasmid and brought about a local and systemic biologic response. This technique holds potential for tumor eradication and immunotherapy of residual cancer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fong Y.
        • Fortner J.
        • Sun R.L.
        • Brennan M.F.
        • Blumgart L.H.
        Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.
        Ann Surg. 1999; 230: 309-318
        • Fong Y.
        • Sun R.L.
        • Jarnagin W.
        • Blumgart L.H.
        An analysis of 412 cases of hepatocellular carcinoma at a Western center.
        Ann Surg. 1999; 229: 790-799
        • Heller L.C.
        • Ugen K.
        • Heller R.
        Electroporation for targeted gene transfer.
        Expert Opin Drug Deliv. 2005; 2: 255-268
        • Tamura T.
        • Sakata T.
        Application of in vivo electroporation to cancer gene therapy.
        Curr Gene Ther. 2003; 3: 59-64
        • Yamashita Y.I.
        • Shimada M.
        • Hasegawa H.
        • Minagawa R.
        • Rikimaru T.
        • Hamatsu T.
        • et al.
        Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.
        Cancer Res. 2001; 61: 1005-1012
        • Daud A.I.
        • DeConti R.C.
        • Andrews S.
        • Urbas P.
        • Riker A.I.
        • Sondak V.K.
        • et al.
        Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
        J Clin Oncol. 2008; 26: 5896-5903
        • Horton H.M.
        • Lalor P.A.
        • Rolland A.P.
        IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial.
        Methods Mol Biol. 2008; 423: 361-372
        • Heller L.C.
        • Heller R.
        Electroporation gene therapy preclinical and clinical trials for melanoma.
        Curr Gene Ther. 2010; 10: 312-317
        • Charpentier K.P.
        • Wolf F.
        • Noble L.
        • Winn B.
        • Resnick M.
        • Dupuy D.E.
        Irreversible electroporation of the pancreas in swine: a pilot study.
        HPB (Oxford). 2010; 12: 348-351
        • Lee E.W.
        • Chen C.
        • Prieto V.E.
        • Dry S.M.
        • Loh C.T.
        • Kee S.T.
        Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.
        Radiology. 2010; 255: 426-433
        • Onik G.
        • Mikus P.
        • Rubinsky B.
        Irreversible electroporation: implications for prostate ablation.
        Technol Cancer Res Treat. 2007; 6: 295-300
        • Rubinsky B.
        • Onik G.
        • Mikus P.
        Irreversible electroporation: a new ablation modality: clinical implications.
        Technol Cancer Res Treat. 2007; 6: 37-48
        • Al-Sakere B.
        • Andre F.
        • Bernat C.
        • Connault E.
        • Opolon P.
        • Davalos R.V.
        • et al.
        Tumor ablation with irreversible electroporation.
        PLoS One. 2007; 2: e1135
        • Guo Y.
        • Zhang Y.
        • Klein R.
        • Nijm G.M.
        • Sahakian A.V.
        • Omary R.A.
        • et al.
        Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.
        Cancer Res. 2010; 70: 1555-1563
        • Neal 2nd, R.E.
        • Singh R.
        • Hatcher H.C.
        • Kock N.D.
        • Torti S.V.
        • Davalos R.V.
        Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode.
        Breast Cancer Res Treat. 2010; 123: 295-301
        • Kingham T.P.
        • Karkar A.M.
        • D'Angelica M.I.
        • Allen P.J.
        • Dematteo R.P.
        • Getrajdman G.I.
        • et al.
        Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
        J Am Coll Surg. 2012; 215: 379-387
        • Martin 2nd, R.C.
        • McFarland K.
        • Ellis S.
        • Velanovich V.
        Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
        J Am Coll Surg. 2012; 215: 361-369
        • Au J.T.
        • Wong J.
        • Mittra A.
        • Carpenter S.
        • Haddad D.
        • Carson J.
        • et al.
        Irreversible electroporation is a surgical ablation technique that enhances gene transfer.
        Surgery. 2011; 150: 474-479
        • Perales M.A.
        • Yuan J.
        • Powel S.
        • Gallardo H.F.
        • Rasalan T.S.
        • Gonzalez C.
        • et al.
        Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.
        Mol Ther. 2008; 16: 2022-2029
        • Inumaru S.
        • Takamatsu H.
        cDNA cloning of porcine granulocyte-macrophage colony-stimulating factor.
        Immunol Cell Biol. 1995; 73: 474-476
        • Delman K.A.
        • Zager J.S.
        • Bennett J.J.
        • Malhotra S.
        • Ebright M.I.
        • McAuliffe P.F.
        • et al.
        Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.
        Ann Surg. 2002; 236: 337-342
        • Karpoff H.M.
        • D'Angelica M.
        • Blair S.
        • Brownlee M.D.
        • Federoff H.
        • Fong Y.
        Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.
        J Clin Invest. 1997; 99: 799-804
        • Malhotra S.
        • Kim T.
        • Zager J.
        • Bennett J.
        • Ebright M.
        • D'Angelica M.
        • et al.
        Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.
        Surgery. 2007; 141: 520-529
        • Alino S.F.
        • Herrero M.J.
        • Noguera I.
        • Dasi F.
        • Sanchez M.
        Pig liver gene therapy by noninvasive interventionist catheterism.
        Gene Ther. 2007; 14: 334-343
        • Fabre J.W.
        • Grehan A.
        • Whitehorne M.
        • Sawyer G.J.
        • Dong X.
        • Salehi S.
        • et al.
        Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava.
        Gene Ther. 2008; 15: 452-462
        • Moonen C.T.
        Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound.
        Clin Cancer Res. 2007; 13: 3482-3489
        • Saito K.
        • Araki K.
        • Reddy N.
        • Guang W.
        • O'Malley Jr., B.W.
        • Li D.
        Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model.
        Head Neck. 2011; 33: 359-367